Directions

NH Nonghyup Tower, 2F near Starbucks

Please call us if you need help finding the clinic. 02.738.7555
Drag
KO
Sign Up Login
02-738-7555
02
738
7555
Naver Booking
Naver Booking
Kakao Consultation
Kakao Consultation
Directions
Directions

Chronic Disease & General Internal Medicine

Steady Care for Everyday and Long-Term Health From chronic conditions such as hypertension, diabetes, and hyperlipidemia
to everyday concerns like a cold or digestive symptoms, The Heart Clinic pairs precise diagnosis with structured,
ongoing management to support your health at every stage.

Weight management and Asia-Pacific BMI classification, from underweight and normal through overweight and obesity classes 1 to 3, with the cardiometabolic risk level for each category. Who should consider the weight management clinic: a BMI of 25 or higher or elevated waist circumference, normal weight with abdominal fat and borderline metabolic results, hypertension, diabetes or high cholesterol, weight management after a stent or heart attack, questions about GLP-1 medication, or diet and exercise that have not worked. Weight-loss goals showing how reductions of 5 percent, 10 to 15 percent, and more than 15 percent can improve blood pressure, blood sugar, lipids, and overall cardiovascular health. Lifestyle changes as the starting point of treatment: managing caloric intake, limiting refined carbohydrates and sugar, exercising at a safe intensity, more daily activity, and cutting back on alcohol.

Types of Weight-Loss Medication

Mounjaro acts on both the GLP-1 and GIP receptors,
and has been shown to produce an average weight loss of roughly 21%. In patients with obesity and heart failure, it has also been shown
to reduce the risk of cardiovascular death and worsening heart failure.

What You Should Know Before Starting Weight-Loss Medication

Obesity medication is considered when lifestyle changes alone are insufficient
or when comorbidities like hypertension, diabetes, dyslipidemia,
or sleep apnea are present. Medication does not replace diet and exercise
it must be combined with lifestyle changes. During treatment, blood pressure,
blood sugar, heart rate, and kidney function are monitored,
and existing BP or diabetes medications may need adjustment as weight changes.

A GLP-1 obesity medication with an average ~8% weight reduction.
In patients with diabetes and high CV risk, reductions in cardiovascular death
and events have been demonstrated.

What You Should Know Before Starting Weight-Loss Medication

Medication does not replace diet and exercise. It should be combined with lifestyle changes and monitored for safety and response.

Helps suppress appetite and reduce food cravings.
Caution is needed for those with uncontrolled hypertension or a history of seizures.

What You Should Know Before Starting Weight-Loss Medication

Medication should be selected according to coexisting conditions and used together with sustainable diet and exercise changes.

A medication that blocks intestinal fat absorption,
which may also help improve fatty liver alongside weight loss.

What You Should Know Before Starting Weight-Loss Medication

Medication should be selected according to coexisting conditions and used together with sustainable diet and exercise changes.

Aids short-term weight loss through appetite suppression,
but may increase heart rate or blood pressure
careful use is required in cardiovascular patients.

What You Should Know Before Starting Weight-Loss Medication

Medication should be selected according to coexisting conditions and used together with sustainable diet and exercise changes.

Injectable medication pens used in obesity treatment

Diagnostic Process

Obesity is more than a number on the scale. It affects the heart, blood vessels, kidneys, and hormones.
The Heart Clinic manages obesity comprehensively alongside cardiovascular risk from a cardiology perspective.

Risk-Based Goals
Set realistic weight-loss goals
based on cardiovascular risk.
Body Composition
Assess body fat, muscle mass,
and abdominal fat.
Weight-Loss Medication
Use GLP-1 medications
with safety and response
monitoring.
Comorbidity Care
Manage hypertension, diabetes,
dyslipidemia, and sleep apnea
together.
Lifestyle Care
Tailor diet and exercise
with ongoing cardiovascular
health monitoring.

Frequently Asked
Questions

A few things worth knowing before your visit.

Can exercise offset the heart risks of excess weight?
Exercise is important, but it cannot fully offset the cardiovascular effects of obesity.
Excess visceral fat can contribute to chronic inflammation, insulin resistance,
and high blood pressure. Even at a normal weight,
excess abdominal fat can increase cardiovascular risk.
Exercise should be combined with body composition management.
Can GLP-1 medications like Wegovy or Mounjaro
be used by people with heart disease?
In fact, these medications have shown even clearer cardiovascular benefits
in patients with obesity who already have heart disease. The SELECT trial (semaglutide) found a 20% reduction in cardiovascular events
among obese patients with existing cardiovascular disease and no diabetes.
The SUMMIT trial (tirzepatide) found a 38% reduction in worsening heart failure among obese patients with heart failure with preserved ejection fraction.
That said, blood pressure and diabetes medication doses may need adjustment during treatment, which is why being managed by a cardiologist matters.
Do I need to take weight-loss medication for life?
Obesity is a chronic condition, similar to high blood pressure or diabetes.
Many patients regain a significant portion of the weight after stopping medication,
so ongoing use is generally the standard approach, with your dose adjusted or
the medication paused through regular monitoring as needed. Even after reaching
your weight-loss goal, continuing with a maintenance-focused treatment plan
is part of managing the condition long-term.
Can GLP-1 medications like Wegovy or Mounjaro
be used by people with heart disease?
In fact, these medications have shown even clearer cardiovascular benefits in patients
with obesity who already have heart disease. The SELECT trial (semaglutide) found
a 20% reduction in cardiovascular events among obese patients with existing
cardiovascular disease and no diabetes. The SUMMIT trial (tirzepatide) found
a 38% reduction in worsening heart failure among obese patients with heart failure
with preserved ejection fraction. That said, blood pressure
and diabetes medication doses may need adjustment during treatment,
which is why being managed by a cardiologist matters.

Information

134 Tongil-ro,
Jongno-gu, Seoul
NH Nonghyup Tower, 2F

Please use elevator No. 13 or 14,
then follow the signs toward Starbucks on the 2nd floor.

※ One hour of free parking is available
in the building during clinic hours.

Clinic Hours

  • Mon - Fri 9:00 AM - 7:00 PM
  • Lunch Break 1:00 PM - 2:00 PM
  • Closed on Saturdays, Sundays
    and Public Holidays
Asan Medical Center Severance Hospital Samsung Medical Center Kangbuk Samsung Hospital Chung-Ang University Hospital Eunpyeong St. Mary's Hospital Yeouido St. Mary's Hospital
Learn More